Buy Crypto Markets Spot FuturesZEC Earn Event Centre Rewards Hub

Ultragenyx Pharmaceutical Inc. (RARE)

NASDAQ

$14.67

$-0.25

(-1.68%)

Regular Market

Ultragenyx Pharmaceutical Inc. (RARE) Live Price Chart

Last updated: ⁦2026-09-09 19:18:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Ultragenyx Pharmaceutical Inc. (RARE) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $14.67, with a market capitalisation of $1.51B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $13.81 to $39.89. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.51B
Open	$14.83
Day's High	$179.65
Day's Low	$13.81
Previous Close	$14.88
Volume	2.16M
Average Volume	3.06M
P/E Ratio	--
52-Week High	$39.89
52-Week Low	$13.81
Dividend Yield	--
Earnings Date	--

Ultragenyx Pharmaceutical Inc. (RARE) Stock Price Today

Ultragenyx Pharmaceutical Inc. (RARE) is currently trading at $14.67 as of 2026-09-09 19:02:50, down 1.41% ($0.21) from the previous close of $14.88

During today's regular trading session, RARE has traded between $13.81 and $179.65, with a trading volume of 2.16M shares. The current price is near the lower end of today's range.

Ultragenyx Pharmaceutical Inc. (RARE) 7-Day Stock Price Change

Over the past seven days, Ultragenyx Pharmaceutical Inc. (RARE) moved from $25.61 to $14.67, representing a decline of 42.72% ($10.94).

The stock traded between $13.81 and $26.80 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 8.17 million shares, up versus the previous seven-day period, indicating higher trading activity.

RARE 52-Week Price Position

Position in Range: 3.3%

52W Low$13.81

52W High$39.89

RARE is currently trading at $14.67, placing it 3.3% of the way from its 52-week low of $13.81 to its 52-week high of $39.89. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Ultragenyx Pharmaceutical Inc. (RARE)?

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.

Ultragenyx Pharmaceutical Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	1371
Exchange	NASDAQ
Company Website	https://www.ultragenyx.com

How to Buy Ultragenyx Pharmaceutical Inc. (RARE) Stock on MEXC

Eligible investors can buy real shares of Ultragenyx Pharmaceutical Inc. (RARE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for RARE and Place Your Order

Open the RealStocks trading page and search for RARE. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Ultragenyx Pharmaceutical Inc. (RARE) share price today?

Ultragenyx Pharmaceutical Inc. (RARE) is currently trading at $ 14.67, down 1.41% ($0.21) from the previous close of $ 14.88. Intraday prices update in real time during regular trading hours.

2.Is RARE stock going up or down today?

As of 2026-09-09 19:02:50, RARE is trading at $ 14.67, down 1.41% ($0.21) from its previous close of $ 14.88. The stock has traded between $ 13.81 and $ 179.65 during today’s regular session. Past price movements do not guarantee future results.

3.What is RARE pre-market price?

As of 2026-09-09 19:02:50, RARE is trading at $ 14.85 in pre-market trading, down 0.17% ($0.03) from the previous close of $ 14.88. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is RARE after-hours price?

As of 2026-09-09 19:02:50, RARE is trading at $ 14.86 in after-hours trading, down 0.13% ($0.02) from the regular-session close of $ 14.88. After-hours prices may differ from the regular session's opening price due to lower liquidity and wider bid-ask spreads.

5.Is RARE stock trading now?

RARE trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does RARE sit relative to its 52-week high and low?

Over the past 52 weeks, RARE has traded between a low of $ 13.81 and a high of $ 39.89. At $ 14.67, the stock is positioned 3.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Ultragenyx Pharmaceutical Inc. in?

Ultragenyx Pharmaceutical Inc. (RARE) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Ultragenyx Pharmaceutical Inc.'s market capitalisation and where is it listed?

Ultragenyx Pharmaceutical Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 1.51B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is RARE valued in terms of P/E ratio and EPS?

RARE trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -5.94. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Ultragenyx Pharmaceutical Inc. pay a dividend?

Ultragenyx Pharmaceutical Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.